Bull & Bear

Figures converted from Chinese renminbi at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the 27-March-2026 binding 90% capital-return resolution sits ~19% above today's market cap and 3+ months of SAMR silence is more consistent with parity-driven clearance than with a Phase 2 setup, but ADS-holder net realisation is still gated on the board's choice of capital-return mechanism. The decisive tension is the SAMR concentration math: bull reads post-deal Shanghai shares of 30/30/30/10 as the structure regulators clear; bear reads a 20-point single-city step where the #4 acquirer absorbs the #3 incumbent as the profile that triggers in-depth review. The bull's leg is binding shareholder law and parity geometry; the bear's leg is founder discretion over mechanism (tender vs dividend), PRC withholding (~10% on the China-to-Cayman dividend), the $150M Dingdong-BVI net-cash floor, and an overseas stub that lost $10.4M on $20.2M of Q1 2026 revenue. Pre-positioning is supported by the floor; full conviction sizing should wait for SAMR clearance paired with a published mechanism implying more than $3.17/ADS realised cash within 12 months of close.

Bull Case

Bull target: $3.75/ADS via sum-of-parts on the announced transaction — 90% × $717M base proceeds ($645M) plus 50% probability-weighted on the $280M pre-closing dividend ceiling ($140M) plus retained HoldCo net cash and international stub, against ~213M ADS outstanding. Timeline: 9–12 months with SAMR clearance expected within a Q3 2026 closing window. Disconfirming signal: SAMR Phase 2 designation or remedy package, a downward purchase-price adjustment from Dingdong BVI failing the $150M net-cash floor at closing, or Chairman Liang invoking Class B control to redirect proceeds away from the 90% mandate.

Bear Case

Bear downside: $1.80/ADS via probability-weighted blend — 50% × SAMR delay/block/repricing (going-concern P/S 0.11× × $3.48B = $385M equity ≈ $1.30/ADS plus residual cash net of overseas losses), 50% × clean close with full leakage (proceeds net of withholding, overseas ring-fence, and floor consumption ≈ $2.20/ADS). Timeline: 12–18 months across SAMR Phase 1/2 designation, expected closing window Q3/Q4 2026, and the first two quarters of post-close mechanism execution. Cover signal: SAMR clearance announced and a published buyback/dividend mechanism that implies more than $3.17/ADS realised cash to ADS holders within 12 months of close — clearance alone is insufficient because founder discretion remains intact.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the durable thesis variable — the 27-March-2026 binding shareholder resolution is the most concrete minority-protection mechanism on a Chinese ADR this report has surfaced, and 3+ months of SAMR silence is more consistent with parity-driven clearance than with a Phase 2 setup. The decisive tension is Tension 1 — the SAMR concentration math — because both Tension 2 (mechanism leakage) and Tension 3 (what the gap is pricing) collapse into the gross-proceeds question once SAMR resolves. The bear could still be right: founder discretion over mechanism, the $150M BVI net-cash floor, PRC withholding, and the overseas-stub ring-fence are all real leakage paths that the 90% mandate does not foreclose, and the going-concern that emerges on deal-break is genuinely compressing (gross margin 30.9%→29.2%, AOV $10.4→$10.1, FY25 OCF -42% YoY). The durable thesis variable is SAMR antitrust treatment plus realised net cash per ADS after mechanism disclosure, not any single calendar print. The verdict flips to Lean Long on a SAMR clearance announcement paired with a published mechanism (record date and per-ADS amount) that pencils to more than $3.17/ADS net within 12 months of close; it flips to Avoid on a SAMR Phase 2 designation, a downward purchase-price adjustment triggered by the BVI floor, or any Class-B-driven redirection of proceeds.